Cost Plus Drugs vs Marek Health
Cost Plus Drugs costs $20 less a month, and both sell semaglutide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Cost Plus Drugs
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Cost Plus Drugs →
Marek Health
Best for: bloodwork inside the monthly price rather than billed on top
Visit Marek Health →If you are choosing between Cost Plus Drugs and Marek Health, the first difference is cost: Cost Plus Drugs is $20 a month cheaper at the entry price. Both prescribe semaglutide, so moving from one to the other would not change your drug. They tie at 7.8 on our six-part score.
Cost Plus Drugs vs Marek Health price
Cost Plus Drugs is the cheaper way in: $279 a month against $299 a month at Marek Health. That is $20 less each month (7% lower), or about $240 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Cost Plus Drugs ($279 a month vs $299 a month).
Medications and formats
Both sell semaglutide.
On format they match: each offers brand-name pens.
Where each one treats patients
Cost Plus Drugs lists 50 states, and Marek Health lists 50 states.
They overlap in 50 states.
Pricing
Cost Plus Drugs
Marek Health
What each price covers
Marek Health's price also covers the clinician visit, the medication itself, shipping, lab work and coaching, which Cost Plus Drugs does not claim.
Cost Plus Drugs does not say what its price includes.
That matters most for the drug: unless Cost Plus Drugs confirms otherwise, budget for medication on top of its listed price.
Cost Plus Drugs
Inclusions not disclosed.
Marek Health
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
In the price
Coaching
In the price
Where each one scores higher
Overall they tie at 7.8 out of 10.
Cost Plus Drugs is stronger on user experience (5.0 vs 2.0).
Marek Health is stronger on support (10.0 vs 5.0).
Value, effectiveness, trust & safety and accessibility are within half a point.
Cost Plus Drugs
7.8/10
Marek Health
7.8/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Cost Plus Drugs nor Marek Health has an FDA warning letter on record with us.
Features & Coverage
| Feature | Cost Plus Drugs | Marek Health |
|---|---|---|
| Starting Price | ✓$279/mo | $299/mo |
| Features | 5 features | ✓8 features |
| States Available | 50 | 50 |
| Compounded | — | — |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Cost Plus Drugs
Cost Plus Drugs is Mark Cuban's transparent-pricing online pharmacy. It sells branded Ozempic at the wholesale acquisition cost plus a 15% markup and a flat $5 pharmacy fee, a margin formula it discloses publicly. There is no telehealth intake; this is pharmacy fulfillment only, shipping to all 50 states. Telehealth platforms that route brand-name semaglutide through similar discount channels are a separate category.
Read our full Cost Plus Drugs review →About Marek Health
There is no published rate. Each protocol gets its own quote. Clients in the US are matched to health coaches and partnered physicians for metabolic care, lab panels of some depth, and tirzepatide or semaglutide. Before a client sees a provider the first time, labs must be drawn; testing repeats at 6-12 weeks and then every 6 months. Alongside the partnered physician sits a Marek Health Coach assigned to that client, checking in routinely twice a year.
Read our full Marek Health review →Pros & Cons
Cost Plus Drugs
What we like
- Semaglutide costs $279 a month, 72% below the $990 median for brand-name semaglutide across the sellers we compare
- Serves all 50 states
- We found no FDA warning letters issued to Cost Plus Drugs
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Marek Health
What we like
- Semaglutide costs $299 a month, 70% below the $990 median for brand-name semaglutide across the sellers we compare
- The monthly price includes the medication, clinician visits, shipping, lab work and coaching
- Serves all 50 states
- We found no FDA warning letters issued to Marek Health
- A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
- Baseline bloodwork is required before a prescription
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
Cost Plus Drugs and Marek Health finish level at 7.8. Cost Plus Drugs is $20 a month cheaper, which makes it the default unless the other covers your state and it does not.
Choose Cost Plus Drugs if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $279 a month.
Choose Marek Health if…
You want bloodwork inside the monthly price rather than billed on top and an opening price near $299 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →Breeze Meds
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $199/mo
Get started →HealthRX
Compounded semaglutide at $133/month
From $133/mo
Get started →Cost Plus Drugs vs Marek Health: FAQ
Close alternatives to Cost Plus Drugs and Marek Health
- Cost Plus Drugs vs JumpstartMD
- Cost Plus Drugs vs Medi-Weightloss
- Cost Plus Drugs vs Superpower
- Marek Health vs JumpstartMD
- Marek Health vs Medi-Weightloss
- Marek Health vs Superpower
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.